Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-15

Clinical Trial Update: Cardiovascular Genistein Therapy for Heart Failure Inflammation [Phase 1, Phase 2]

View source ↗

Summary

An ongoing Phase 1/2 clinical trial evaluating genistein therapy for inflammation in heart failure, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Genistein (genistein)

Snippet

Sponsor: University Medical Centre Ljubljana | Conditions: Heart Failure | Phase 1, Phase 2 | Status: RECRUITING